Ontario Bioscience Innovation Organization – CAAP – Building Companies


OBIO® Capital Access Advisory Program (CAAP®), a 9-month structured program for health science companies is designed to operate downstream from existing entrepreneurship programs and focuses on accelerating technology commercialization, working towards Series A financing and strategic partnerships. CAAP® covers three fundamental business themes:
1. Business strategic planning & increasing the ROI for investors;
2. Advanced fundraising strategies & financial modeling;
3. Closing an investment round.

Comments on Funding:

No funding provided.


Applicants must be:

  • health science companies;
  • starting to raise Series A financing in Q4 2022 to 2023 timeframe.

Program Contact:


Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *